Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

BACKGROUND: The immunogenicity and safety of an adjuvanted herpes zoster subunit (HZ/su) vaccine when coadministered with a quadrivalent seasonal inactivated influenza vaccine (IIV4) was investigated in a phase 3, open-label, randomized clinical trial in adults aged ≥50 years. METHODS: Subjects were...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Tino F, Aggarwal, Naresh, Moeckesch, Beate, Schenkenberger, Isabelle, Claeys, Carine, Douha, Martine, Godeaux, Olivier, Grupping, Katrijn, Heineman, Thomas C, Fauqued, Marta Lopez, Oostvogels, Lidia, Van den Steen, Peter, Lal, Himal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853904/
https://www.ncbi.nlm.nih.gov/pubmed/29029224
http://dx.doi.org/10.1093/infdis/jix481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853904/
https://www.ncbi.nlm.nih.gov/pubmed/29029224
http://dx.doi.org/10.1093/infdis/jix481

Ejemplares similares